Trial Profile
Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2021
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Malignant thymoma
- Focus Therapeutic Use
- 02 Apr 2021 Status changed from active, no longer recruiting to completed.
- 18 Oct 2017 Results presented at the 18th World Conference on Lung Cancer
- 12 Sep 2017 Results presented at the 42nd European Society for Medical Oncology Congress